Note: Not all species have been tested for usefulness with this product. Only those species listed have been tested. We cannot make any guarantees about additional reactivities which may or may not occur.
The antiserum was produced against synthesized phosphopeptide derived from human p44/42 MAP Kinase around the phosphorylation site of threonine 202 (F-L-TP-E-Y).
Modification:
Thr202
Species Reactivity:
This antibody is reactive against Human, Mouse, Rat
Applications:
Uses:
This antibody is useful for: Western Blot 1:500-1:1000 immunohistochemistry-Paraffin 1:50-1:100
Dilutions:
Immunohistochemistry-Paraffin, Western Blot 1:500-1:1000
Aliquot and store at -20 °C or -80 °C. Avoid freeze-thaw cycles.
Buffer:
phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, and 50% glycerol.
Preservative:
0.02% Sodium Azide
Limitations:
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Products are guaranteed for 6 months from date of receipt, except for peptides and proteins which are guaranteed for 3 months.
p44 MAP kinase aka ERK1 is ubiquitously expressed in various tissues and cells. It is activated by phosphorylation of neighbouring serine and threonine residues by MEK1 and MEK2 in response to diverse stimuli such as growth factors and mitogens.
Western Blot: p44/42 MAP Kinase Phosphospecific Antibody [NB100-82101] - Western blot analysis of extracts from MCF7, 293, A431, A2780 and Hela cells, using p44/42 MAP Kinase antibody (Lanes 1 2 3 4 ) and p44/42 MAP Kinase (phospho-Thr202) antibody (Lanes 5 6 7 8).
Immunohistochemistry: p44/42 MAP Kinase Phosphospecific Antibody [NB100-82101] - Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using p44/42 MAP Kinase (phospho-Thr202) antibody